Can a Mosaic Fetal Cell Line with an Extra Ring Chromosome Cause Fetal Hydrops?
Yes, a mosaic fetal cell line containing an extra ring chromosome can definitively cause fetal hydrops, as chromosomal abnormalities account for 7-16% of all nonimmune hydrops fetalis (NIHF) cases, and ring chromosomes represent a recognized genetic etiology within this category. 1
Mechanism and Evidence
Chromosomal abnormalities cause fetal hydrops through several pathophysiologic mechanisms, including:
- Cardiac anomalies leading to increased central venous pressure
- Lymphatic dysplasia resulting in impaired venous return
- Abnormal myelopoiesis affecting hematologic function 1
Ring chromosomes specifically can disrupt normal fetal development through gene dosage imbalances and structural chromosomal instability. The 2015 SMFM guidelines explicitly identify chromosomal abnormalities as one of the three most common causes of NIHF, alongside cardiovascular and hematologic abnormalities 1.
Direct Case Evidence
A compelling case report 2 documented a de novo ring chromosome 21 in a fetus presenting with hydrops, demonstrating the direct causal relationship. This case is particularly instructive because it highlights that even complex chromosomal rearrangements involving ring chromosomes can manifest as hydrops fetalis.
Additional case evidence 3 describes a fetus with mosaicism for ring chromosome 2 [karyotype: 45,XY,-25/46,XY,r(2)(p25q37)55] presenting with intrauterine growth retardation and cardiovascular malformations—features commonly associated with the hydrops spectrum.
Clinical Context
The mosaic nature of the cell line is particularly relevant because:
- Mosaicism does not exclude hydrops development—the phenotypic severity depends on the proportion of abnormal cells, the specific chromosome involved, and the tissues affected 4
- Historical data shows chromosomal disorders account for 15.7% of genetic causes in NIHF, with genetic abnormalities overall representing >35% of cases 5
- More recent comprehensive studies confirm that genetic causes account for approximately 35% of hydrops cases 6
Diagnostic Approach
When encountering fetal hydrops, the SMFM guidelines mandate 1:
Immediate workup includes:
- Karyotype and/or chromosomal microarray analysis (CMA)—regardless of whether structural anomalies are present
- Detailed ultrasound with fetal echocardiography
- Middle cerebral artery Doppler to assess for anemia
Critical pitfall: Standard noninvasive prenatal testing (NIPT) may fail to detect ring chromosomes and complex chromosomal rearrangements, as demonstrated in the ring 21 case where NIPT was falsely reassuring 2. This underscores the necessity of invasive diagnostic testing (amniocentesis or cordocentesis) when hydrops is identified.
Prognosis Considerations
Aneuploidy and chromosomal abnormalities confer a poor prognosis in the setting of fetal hydrops 1. Even in the absence of aneuploidy, neonatal survival with NIHF is often <50%. The specific prognosis for ring chromosome mosaicism depends on:
- The chromosome involved
- The percentage of abnormal cells
- Associated structural anomalies
- Gestational age at diagnosis
The presence of hydrops in the context of chromosomal abnormality significantly worsens outcomes compared to isolated chromosomal findings without hydrops.